相关实验视频
Updated: Jan 16, 2026
10:58
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
11.4K
医院容量与卵巢癌的结果之间的关联:系统性审查
Qing Luo1, Yan Wang1, Xiaoyun Zhang1
1Department of Gynaecology and Obstetrics, Jiuquan People's Hospital, Jiuquan, Gansu, China.
Frontiers in surgery
|September 29, 2025
概括
在高人数的医院治疗卵巢癌 (OC) 显著改善了患者的生存率和手术质量. 集中OC护理可能会优化结果,并为更好的患者结果提供政策决策的信息.
科学领域:
- 在瘤学瘤学.
- 手术结果研究研究.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 医院手术体积是卵巢癌 (OC) 结果的决定因素之一,但证据仍然不一致.
- 以前的研究表明,医院体积和OC患者预后之间存在联系.
- 了解这种关联对于优化癌症护理提供至关重要.
研究的目的:
- 系统地评估在卵巢癌 (OC) 患者的医院外科手术体积和结果之间的关联.
- 综合观察性研究的证据,以了解医院体积对OC存活率和护理质量的影响.
- 提供数据驱动的洞察力,了解有关OC治疗集中化的潜在政策变化.
主要方法:
- 在PubMed,Embase和Cochrane图书馆进行了系统的文献搜索,直到2025年1月.
- 分析包括了15项观察性研究,包括超过10万名OC患者.
- 采用了定性合成方法来分析提取的数据.
主要成果:
- 在15项研究中,有13项研究发现,高人数医院的治疗显著改善了OC患者的整体存活率 (OS).
- 高体积的中心显示,术后和90天死亡率较低,救援失败率也较低.
- 手术质量指标,包括完整的细胞减小和淋巴切除术,在高体积环境中始终更高,并与更好的并发症管理相结合.
结论:
- 较高的医院外科手术量与卵巢癌患者的改善生存率,降低死亡率和优越的外科手术质量密切相关.
- 将卵巢癌护理集中到高人数中心是一个可行的战略,以优化患者的治疗结果.
- 这些发现支持在卵巢癌治疗政策规划中考虑护理集中.
相关概念视频
01:21Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K